RE:RE:RE:RE:RE:Q1 Out
You think Mint, Natco and Glenmark in Canada are "large"? No they are not and they received listings that are in the range of $3M-$10M each with new product listings with banners and accounts. If you had access to competitive IMS data you would see market growth and all generic growth and then Vanc which is way below industry. Again im talking generic companies in Canada, not brand companies. The concern I see is that they ship product, ex-factory, into wholesalers (ie McKesson or K&F) but have trouble moving ALL that product out to pharmacy. It ages and comes back as short dated. Also you will continue to see write downs on stock due to aging inventory when you see when they brought in product and how long its been in Canada. Their average stability 2 years with some possibilities of 3 years. The industry wants product with 1 year dating, CAPDM papers recommend 9 months dating and manufactures do a full stock on product that has 6 months dateing left. This is a concern with the aging product they have and that is in the Canadian supply chain.